RRAD Promotes EGFR-Mediated STAT3 Activation and Induces Temozolomide Resistance of Malignant Glioblastoma
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0244
Full Text
Open PDFAbstract
Available in full text
Date
October 13, 2014
Authors
Publisher
American Association for Cancer Research (AACR)